Senti Biosciences News

Senti Biosciences | 8-K: Current report

Jul 17 16:17 ET

Senti Biosciences | 8-K: Current report

Jul 16 16:08 ET

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Mathers Edward T

Jul 12 16:35 ET

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Farokhzad Omid

Jul 12 16:22 ET

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director COOPERSTONE BRENDA

Jul 12 16:19 ET

Senti Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Collins James J.

Jul 12 16:18 ET

Senti Biosciences | 8-K: Current report

Jul 12 16:18 ET

Senti Biosciences | DEF 14A: Definitive information statements

May 29 16:26 ET

Senti Biosciences | ARS: Annual Report to Security Holders

May 29 16:20 ET

Senti Biosciences | DEFA14A: Others

May 29 16:17 ET

Senti Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition

May 17 17:23 ET

Senti Biosciences | 8-K: Current report

May 17 17:18 ET

Senti Biosciences | 8-K: Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights

May 9 17:09 ET

Senti Biosciences | 10-Q: Q1 2024 Earnings Report

May 9 17:04 ET

Senti Biosciences | 3: Initial statement of beneficial ownership of securities-Officer Li Yvonne

May 9 16:27 ET

Senti Biosciences | 8-K: Current report

May 2 16:31 ET

Senti Biosciences | 10-K/A: Annual report (Amendment)

Apr 26 17:05 ET

Senti Biosciences | 8-K: Current report

Apr 26 17:00 ET

Senti Biosciences | 10-K: FY2023 Annual Report

Mar 21 22:21 ET

Senti Biosciences | 8-K: Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights

Mar 21 16:19 ET